![Labs in Court: Lab Settles Kickback Allegations for $5.9M](https://www.g2intelligence.com/wp-content/uploads/2023/05/May23.LCA_.LabsInCourt-iStock-1100x800-1-1080x675.jpg)
Labs in Court: Lab Settles Kickback Allegations for $5.9M
Two companies settle kickback and FCA-related claims, a qui tam case is tossed, and a lab tech loses a workplace harassment case.
Two companies settle kickback and FCA-related claims, a qui tam case is tossed, and a lab tech loses a workplace harassment case.
In an analysis of enforcement actions from the end of 2022 to early spring 2023, cases involving urine drug testing were the most prevalent.
A False Claims Act whistleblower lawsuit can do significant damage to your lab and its reputation, even if the case lacks truth and merit.
In the latest major COVID-19-related enforcement action, 18 individuals were charged in various schemes worth more than $490 million.
Last week’s lone lab-related enforcement action involved a prison sentence for a woman posing as a licensed physician’s assistant.